"Im Kinderkrankenhaus Wilhelmstift befinden sich 23 Fachbereiche unter einem Dach, die eine "medizinische Versorgung der kurzen Wege" ermöglichen. Die interdisziplinäre Zusammenarbeit zwischen den Teams der Fachbereiche und der 21 Sprechstunden des Wilhelmstifts bildet die Grundlage für Spitzenmedizin, die weit über die Grenzen Norddeutschlands hinaus Anerkennung findet."

During the past decade, Kath. Kinderkrankenhaus Wilhelmstift conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kath. Kinderkrankenhaus Wilhelmstift" #1 sponsor was "Eli Lilly and Company" with 1 trials, followed by "Incyte Corporation" with 1 trials sponsored, "LEO Pharma" with 1 trials sponsored, "Mayne Pharma International Pty Ltd" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kath. Kinderkrankenhaus Wilhelmstift" #1 collaborator was "German Research Foundation" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Roche Diagnostics" with 1 trials as a collaborator and "University of Luebeck" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kath. Kinderkrankenhaus Wilhelmstift" are "Atopic Dermatitis" (3 trials), "Diabetes Mellitus, Insulin-Dependent" (1 trials), "Infantile Hemangioma" (1 trials), "Lamellar Ichthyosis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Kath. Kinderkrankenhaus Wilhelmstift" in a lesser frequency.

Most popular intervention types in "Kath. Kinderkrankenhaus Wilhelmstift" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Baricitinib" (1 trials), "CD5789 Cream 100 µg/g" (1 trials), "CD5789 Cream 200 µg/g" (1 trials) and "CD5789 Cream Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kath. Kinderkrankenhaus Wilhelmstift" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Kath. Kinderkrankenhaus Wilhelmstift". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kath. Kinderkrankenhaus Wilhelmstift, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kath. Kinderkrankenhaus Wilhelmstift, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".